Morgan Stanley Maintains Overweight on Astera Labs, Raises Price Target to $74
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Joseph Moore has maintained an Overweight rating on Astera Labs (NASDAQ:ALAB) and raised the price target from $55 to $74.
October 09, 2024 | 11:44 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has increased its price target for Astera Labs from $55 to $74, maintaining an Overweight rating. This suggests a positive outlook for the company's stock.
The increase in price target from $55 to $74 by a reputable firm like Morgan Stanley indicates a strong positive sentiment towards Astera Labs' future performance. The Overweight rating suggests that the stock is expected to outperform its peers, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100